Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3366
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT05257473 | Defining Endpoints in Becker Muscular Dystrophy | ||
| NCT04849273 | A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC | ||
| NCT04709705 | DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) | ||
| NCT05597345 | Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma | ||
| NCT07225361 | Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis | ||
| NCT04294472 | A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients | ||
| NCT04442022 | A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
| NCT06663137 | Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC | ||
| NCT07090330 | ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis | ||
| NCT06804824 | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors | ||
| NCT04892641 | Phase 1 Study of Epetraborole Tablets | ||
| NCT02657005 | TK216 in Patients With Relapsed or Refractory Ewing Sarcoma | ||
| NCT03455829 | G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer | ||
| NCT05007418 | Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma | ||
| NCT06944379 | ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose | ||
| NCT02117362 | Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma | ||
| NCT04902703 | Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease | ||
| NCT01016873 | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD | ||
| NCT02811159 | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | ||
| NCT07121946 | This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma | ||
| NCT01292070 | Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy | ||
| NCT00434369 | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | ||
| NCT06076681 | A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules | ||
| NCT06479382 | Study of the ETX-4143 2.0 Device in Subjects With Eye Pain | ||
| NCT04018027 | Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis | ||
| NCT06658951 | Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors | ||
| NCT03787602 | Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma | ||
| NCT02127970 | Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | ||
| NCT05418673 | A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale | ||
| NCT03178201 | TGR1202 in Relapsed and Refractory Follicular Lymphoma | ||
| NCT00298181 | YSPSL for Prevention of Delayed Graft Function Part A | ||
| NCT05298332 | Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects | ||
| NCT02468414 | TARGTEPO Treatment for Anemia in PD US Trial | ||
| NCT01202149 | Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis | ||
| NCT01997190 | Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion | ||
| NCT05110846 | A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus | ||
| NCT04259086 | Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines | ||
| NCT02973269 | DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis | ||
| NCT05913232 | Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension | ||
| NCT04985916 | ET-01 in Subjects With Lateral Canthal Lines, LCL-210 | ||
| NCT03054363 | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | ||
| NCT04076540 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy Volunteers | ||
| NCT03935568 | A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects | ||
| NCT05705466 | Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer | ||
| NCT00884234 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
| NCT00605826 | A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence | ||
| NCT02722278 | A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | ||
| NCT04801017 | A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects | ||
| NCT03380390 | Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea |
